申请人:Boehringer Markus
公开号:US20060135512A1
公开(公告)日:2006-06-22
The present invention relates to compounds of formula (I)
wherein R
1
is as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
本发明涉及式(I)的化合物,其中R1如描述和权利要求中定义的那样,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与DPP-IV相关的疾病,如糖尿病,特别是非胰岛素依赖型糖尿病和糖耐量受损。